XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock-based Compensation Stock-based CompensationStock-based compensation expense reflects share awards issued under the Company's 2018 virtual stock option plan and the Long Term Incentive Plan adopted in 2020 (the "LTIP"). For the three months ended March 31, 2022 and 2021, the Company recognized total stock-based compensation expense for all the plans of $0.5 million and $1.0 million, respectively, which is included as a component of Other operating expenses in the Consolidated Statements of Operations and Comprehensive Loss.
2020 Long Term Incentive Plan

In connection with the adoption of the LTIP, the Administrative Board authorized for 2020 the issuance of virtual options for up to three million ADSs, including up to one million zero-priced options. In 2021, the Administrative Board authorized the issuance of an additional 500,000 ADSs, which can be used for the issuance of both options and zero-priced options. The additional authorized ADSs were used in connection with the options granted in the first quarter of 2022. As of March 31, 2022, 215,833 virtual options, and 208,867 zero-priced options were available for future grant under the LTIP.

The fair value of the virtual stock options and zero-priced options are measured using a Black-Scholes option-pricing model for the three months ended March 31, 2022. The inputs used in the measurement of the fair values at the date of grant are summarized below:

Virtual Stock OptionsZero-Priced Options
Long CallShort CallLong CallShort Call
OptionOption (Cap)OptionOption (Cap)
Stock price$2.70$2.70$2.70$2.70
Strike price$2.93$29.30$—$50.00
Term4.654.654.654.65
Volatility65.0%65.0%65.0%65.0%
Dividend—%—%—%—%
Risk-free rate2.4%2.4%2.4%2.4%

The following table summarizes the activity for the Company's options under the LTIP during the three months ended March 31, 2022:

Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
(in years)
Outstanding as of December 31, 20211,802,228$4.715.62$0.01
Granted530,0002.93
Forfeited(48,061)5.24
Outstanding as of March 31, 20222,284,1674.295.760.01
Vested and exercisable at March 31, 2022684,513$4.814.95$0.01

Number of OptionsWeighted Average Grant Date Fair Value
Unvested as of December 31, 20211,190,967$2.53
Granted530,0001.20
Vested(73,252)3.03
Forfeited(48,061)2.56
Unvested as of March 31, 20221,599,654$2.06
The following table summarizes the activity for the Company's zero priced options under the LTIP during the three months ended March 31, 2022:

Number of Options
Outstanding as of December 31, 2021584,068
Granted220,000
Forfeited(12,935)
Outstanding as of March 31, 2022791,133
Vested and exercisable at March 31, 2022104,233

Number of OptionsWeighted Average Grant Date Fair Value
Unvested as of December 31, 2021514,370$5.29
Granted220,0002.59
Vested(34,535)6.21
Forfeited(12,935)5.35
Unvested as of March 31, 2022686,900$4.38

The total unrecognized compensation expense related to awards granted under the LTIP at March 31, 2022 was $3.2 million, which will be recognized over a weighted-average period of 3.00 years.

As of March 31, 2022 and 2021, diluted loss per share excludes 1,096,902 and 806,280 potentially dilutive common shares, respectively, related to vested option awards, as their effect was anti-dilutive.